1.15
price up icon2.68%   0.03
after-market Dopo l'orario di chiusura: 1.15
loading

Evogene Ltd Borsa (EVGN) Ultime notizie

pulisher
Jan 06, 2026

Evogene (NASDAQ:EVGN) Stock Passes Below Fifty Day Moving Average – Time to Sell? - Defense World

Jan 06, 2026
pulisher
Jan 02, 2026

Panic Selling: Will Evogene Ltd stock remain a Wall Street favorite2025 Price Targets & Low Drawdown Trading Strategies - moha.gov.vn

Jan 02, 2026
pulisher
Dec 31, 2025

Evogene Appoints Dr. Olga Nissan as Vice President of Business Development to Drive AI-Driven Growth - The Globe and Mail

Dec 31, 2025
pulisher
Dec 30, 2025

Evogene appoints Dr. Olga Nissan as VP of business development By Investing.com - Investing.com Nigeria

Dec 30, 2025
pulisher
Dec 30, 2025

Evogene appoints Nissan as VP of Business Development - TipRanks

Dec 30, 2025
pulisher
Dec 30, 2025

Evogene appoints Dr. Olga Nissan as VP of business development - Investing.com

Dec 30, 2025
pulisher
Dec 30, 2025

Evogene Announces Appointment of Dr. Olga Nissan as its Vice President of Business Development - Barchart.com

Dec 30, 2025
pulisher
Dec 21, 2025

How Evogene Ltd. stock compares to industry benchmarks2025 Support & Resistance & AI Powered Market Trend Analysis - Улправда

Dec 21, 2025
pulisher
Dec 19, 2025

Will Evogene Ltd. stock remain a Wall Street favoriteQuarterly Growth Report & Smart Allocation Stock Reports - Bölüm Sonu Canavarı

Dec 19, 2025
pulisher
Dec 19, 2025

Is Evogene Ltd. stock resilient to inflationJuly 2025 Setups & Free Daily Entry Point Trade Alerts - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

Will Evogene Ltd. stock benefit from upcoming earnings reportsJuly 2025 Drop Watch & AI Based Trade Execution Alerts - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

Can Evogene Ltd. stock sustain market leadershipWeekly Gains Report & Safe Capital Investment Plans - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

Can Evogene Ltd. stock sustain free cash flow growth2025 Price Momentum & Entry and Exit Point Strategies - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

Should I hold or sell Evogene Ltd. stock in 20252025 Volume Leaders & Technical Buy Zone Confirmation - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

Why Evogene Ltd. stock appeals to dividend seekersJuly 2025 Technicals & Weekly High Conviction Ideas - DonanımHaber

Dec 19, 2025
pulisher
Dec 18, 2025

Is Evogene Ltd. stock attractive for growth ETFsBreakout Watch & Intraday High Probability Setup Alerts - Улправда

Dec 18, 2025
pulisher
Dec 18, 2025

New Highs: How Evogene Ltd. stock compares to industry benchmarksVolume Spike & Consistent Return Strategy Ideas - Улправда

Dec 18, 2025
pulisher
Dec 18, 2025

Will Evogene Ltd. stock keep outperforming rivalsWeekly Stock Recap & Growth Focused Investment Plans - Улправда

Dec 18, 2025
pulisher
Dec 17, 2025

Reviewing Vera Therapeutics (NASDAQ:VERA) & Evogene (NASDAQ:EVGN) - Defense World

Dec 17, 2025
pulisher
Dec 11, 2025

Will Introduced Innovation Sustain VLS Finance Limiteds GrowthInterest Rate Changes & Superior Trading Strategies - earlytimes.in

Dec 11, 2025
pulisher
Dec 08, 2025

Investment Recap: Is Evogene Ltd stock a smart buy before Fed meetingTrade Entry Report & Free Growth Oriented Trading Recommendations - BỘ NỘI VỤ

Dec 08, 2025
pulisher
Dec 06, 2025

Evogene (NASDAQ:EVGN) Stock Crosses Below Two Hundred Day Moving Average – Time to Sell? - Defense World

Dec 06, 2025
pulisher
Dec 05, 2025

How AI Is Breaking Down the Bottlenecks in Small Molecule Drug Discovery - Unite.AI

Dec 05, 2025
pulisher
Dec 02, 2025

Evogene (EVGN) Stock Analysis Report | Ratings, Financials & Performance - Benzinga

Dec 02, 2025
pulisher
Nov 28, 2025

12 Health Care Stocks Moving In Friday's After-Market Session - Sahm

Nov 28, 2025
pulisher
Nov 28, 2025

Evogene (NASDAQ:EVGN) Share Price Passes Below Two Hundred Day Moving Average – What’s Next? - Defense World

Nov 28, 2025
pulisher
Nov 25, 2025

Evogene Announces Completion of Transaction for the Sale of Lavie Bio's Activity to ICL (PR Newswire) - Aktiellt

Nov 25, 2025
pulisher
Nov 23, 2025

Evogene shares climb 5% as cost reductions help deliver earnings beat - MSN

Nov 23, 2025
pulisher
Nov 23, 2025

Evogene Ltd. Reports Strategic Shift and Financial Results - MSN

Nov 23, 2025
pulisher
Nov 22, 2025

Evogene Ltd. Earnings Call: Strategic Shifts and Optimism - The Globe and Mail

Nov 22, 2025
pulisher
Nov 21, 2025

Is Evogene Ltd. stock cheap compared to fundamentals - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Evogene Ltd. (NASDAQ:EVGN) Q3 2025 Earnings Call Transcript - Insider Monkey

Nov 21, 2025
pulisher
Nov 21, 2025

Can Evogene Ltd. stock hit record highs again2025 Sector Review & Accurate Entry/Exit Alerts - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Is Evogene Ltd. stock oversold or undervalued2025 Key Highlights & Free Real-Time Volume Trigger Notifications - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

Evogene: Q3 Earnings Snapshot - Stamford Advocate

Nov 20, 2025
pulisher
Nov 20, 2025

Evogene earnings beat by $0.12, revenue fell short of estimates - Investing.com Australia

Nov 20, 2025
pulisher
Nov 20, 2025

Evogene Q3 2025 Earnings Call Transcript - MarketBeat

Nov 20, 2025
pulisher
Nov 20, 2025

Earnings Call Summary | Evogene(EVGN.US) Q3 2025 Earnings Conference - 富途牛牛

Nov 20, 2025
pulisher
Nov 20, 2025

Earnings call transcript: Evogene reports Q3 2025 earnings beat amid restructuring - Investing.com India

Nov 20, 2025
pulisher
Nov 20, 2025

Evogene shares rise 5% as cost-cutting measures drive earnings beat - Investing.com Nigeria

Nov 20, 2025
pulisher
Nov 20, 2025

Evogene Reports Third Quarter 2025 Financial Results - The AI Journal

Nov 20, 2025
pulisher
Nov 20, 2025

Evogene Reports Q3 2025 Financial Results Amid Strategic Shift - TipRanks

Nov 20, 2025
pulisher
Nov 20, 2025

Israeli biotech firm Evogene's Q3 revenue misses estimates due to reduced seed sales - TradingView

Nov 20, 2025
pulisher
Nov 20, 2025

Evogene shares rise 5% as cost-cutting measures drive earnings beat By Investing.com - Investing.com South Africa

Nov 20, 2025
pulisher
Nov 20, 2025

Evogene : Q3 2025 Consolidated Financial Statements - MarketScreener

Nov 20, 2025
$40.65
price up icon 2.52%
$33.10
price up icon 4.09%
$106.66
price up icon 4.78%
$98.09
price up icon 1.28%
biotechnology ONC
$320.35
price up icon 0.02%
$175.07
price down icon 0.07%
Capitalizzazione:     |  Volume (24 ore):